In the current study, we investigated the difference of LAT1 expression between pemetrexed-sensitive and resistant NSCLC cells and the involvement of LAT1 in CSC activity of NSCLC cell lines. The gene discussed is LAT; the disease is non-small cell lung carcinoma.